EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

G1 and G2 variants of apolipoprotein L1 among Central African population in Trypanosoma brucei gambiense endemic rural area

Dominique M Mupepe, Marie-Noelle Nl Wameso, Hippolyte N Situakibanza, Pépé M Ekulu, Jean Robert R Makulo, Jean Marie N Kayembe, Agathe B Nkoy, Raggue Zm Mvibudulu, Lambertus P Van den Heuvel, Elena N Levtchenko, Kevin L Karume, Victoire A Bikoumou und 4 weitere

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.19495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Dominique M Mupepe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, University Hospital of Kinshasa, University of Kinshasa, The Democratic Republic of the Cong…. Hauptthemen laut MEDLINE: Apolipoprotein L1, Trypanosomiasis, African, Trypanosoma brucei gambiense, Rural Population. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Apolipoprotein L1 (APOL1) risk variants (G1, G2) are known to enhance the protective ability against human African trypanosomiasis (HAT), in addition to their role in kidney and cardiovascular disease. The effects of these variants on trypanosome infection could differ regionally owing to local adaptations of the host and pathogen. This study explored APOL1 risk variants distribution in HAT-infected and non-infected populations from a rural Trypanosoma brucei gambiense (T. b. gambiense) endemic area in Central Africa. Methodology: We conducted a cross-sectional study with 124 participants in Masimanimba, a HAT-endemic region in the Democratic Republic of the Congo (DRC). Student’s and Pearson`s Chi-square test or Fisher’s exact tests were used as appropriate. Statistical significance was set at p < 0.05, based on two-tailed test.

Results

71 participants (57%) were infected by Trypanosoma, 65 (52%) of whom were symptomatic and 6 (5%) asymptomatic. The overall frequency of risk alleles was 16.5% for G1 and 8.8% for G2. Neither variant was associated with the susceptibility to T. b. gambiense infection (for G1: 19.7% vs. 26.4 %; OR: 0.68 [95% CI: 0.29–1.62], p = 0.394; for G2: 11.3% vs. 13.2% 0.83 [0.27–2.58], p = 0.786). All of the G2 variants were found in symptomatic patients Conclusions: APOL1 variants are common in populations living in T. b. gambiense endemic areas of the DRC. Neither variant was associated with susceptibility to T. b. gambiense. The G2 variant was the only one associated with symptomatic HAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein L1Trypanosomiasis, AfricanTrypanosoma brucei gambienseRural PopulationHumansCross-Sectional StudiesMaleAdultFemaleMiddle AgedYoung AdultDemocratic Republic of the CongoEndemic DiseasesAdolescentAgedGenotypeGenetic Variation

Stichwörter der Autor:innen

APOL1 variantsDR Congoendemictrypanosomiasis

Substanzen

Apolipoprotein L1APOL1 protein, human

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, University Hospital of Kinshasa, University of Kinshasa, The Democratic Republic of the Congo.
  • Service of Nephrology, Department of Internal Medicine, University Hospital of Kinshasa, University of Kinshasa, The Democratic Republic of the Congo.
  • Service of Infectious and Parasitic Pathologies, Department of Tropical Medicine, University Hospital of Kinshasa, University of Kinshasa, The Democratic Republic of the Congo.
  • Pediatric Nephrology Unit, Department of Pediatrics, University Hospital of Kinshasa, University of Kinshasa, The Democratic Republic of the Congo.
  • Service of Pneumology, Department of Internal Medicine, University Hospital of Kinshasa, University of Kinshasa, The Democratic Republic of the Congo.
  • Department of Development and Regeneration, KU Leuven, B 3000 Leuven, Belgium.

Zitieren

APA

Mupepe, D. M., Wameso, M. N., Situakibanza, H. N., Ekulu, P. M., Makulo, J. R. R., Kayembe, J. M. N., Nkoy, A. B., Mvibudulu, R. Z., Van den Heuvel, L. P., Levtchenko, E. N., Karume, K. L., Bikoumou, V. A., Buila, N. B., Longo, B. M., Mumba, D. N., & M'Buyamba-Kabangu, J. R. (2024). G1 and G2 variants of apolipoprotein L1 among Central African population in Trypanosoma brucei gambiense endemic rural area. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19495

Vancouver

Mupepe DM, Wameso MN, Situakibanza HN, Ekulu PM, Makulo JRR, Kayembe JMN, et al. G1 and G2 variants of apolipoprotein L1 among Central African population in Trypanosoma brucei gambiense endemic rural area. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19495

BibTeX
@article{Mupepe2024,
  author = {Mupepe, Dominique M and Wameso, Marie-Noelle Nl and Situakibanza, Hippolyte N and Ekulu, Pépé M and Makulo, Jean Robert R and Kayembe, Jean Marie N and Nkoy, Agathe B and Mvibudulu, Raggue Zm and Van den Heuvel, Lambertus P and Levtchenko, Elena N and Karume, Kevin L and Bikoumou, Victoire A and Buila, Nathan B and Longo, Benjamin M and Mumba, Dieudonné N and M'Buyamba-Kabangu, Jean René},
  title = {G1 and G2 variants of apolipoprotein L1 among Central African population in Trypanosoma brucei gambiense endemic rural area},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.19495}
}
Kostenlos starten →